ABOS icon

Acumen Pharmaceuticals
ABOS

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$7
123% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Thomas Shrader
100% 1-yr ABOS win rate
27 Jan ‘26 1 month ago